Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 10 Fast-growings companies in Hyperlipidemia
by Most Patent Filing In 5 Years in the Japan in 2022

The Hyperlipidemia top 10 is Discovery PatSnap’ annual ranking of the top 10 Most Patent Filing In 5 Years Hyperlipidemia Fast-growings in the Japan. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Hyperlipidemia is abnormally elevated levels of any or all lipids or lipoproteins in the blood. It is the most common form of dyslipidemia (which includes any abnormal lipid levels). Lipids (water-insoluble molecules) are transported in a protein capsule. The size of that capsule, or lipoprotein, determines its density. The lipoprotein density and type of apolipoproteins it contains determines the fate of the particle and its influence on metabolism.
Page generation time: May 21 2025